Presentation of Med-TSO Winter Outlook 2023-24

On Wednesday, 29 November, Med-TSO experts presented our fourth probabilistic power system adequacy assessment for the Mediterranean region in a public webinar.

The Winter Outlook 2023-24 supplies elements to assess if a specific country would have enough capacity to cover power demand even under severe or extreme conditions during the following winter months. It also helps to understand how the interconnections would contribute to the reduction of eventual shortage situations. The assessment involves Morocco, Algeria, Tunisia, Libya, Egypt, Jordan, and Lebanon, and it is the only one performed among non-EU Med-TSO members.

Med-TSO’s members acknowledged that these Mediterranean adequacy assessments could provide TSOs and relevant stakeholders comprehensive support to make balanced and consistent decisions about their power systems’ adequacy level. A power system is adequate when sufficient production and import capacity allow it to meet the demand, guaranteeing the security of supply.

Insights from the webinar

Med-TSO Secretary General Angelo Ferrante opened the webinar, welcoming the attendees and underlining that this outlook is the first-ever assessment study entirely realised thanks to Med-TSO’s internal resources. Then, Simone Biondi, Teasimed 2 Project Manager, gave an overview of the adequacy assessment studies and the methodology used in our ongoing project TEASIMED 2.

Ahmed Elshami, Med-TSO Power System and Adequacy Studies advisor, took the floor going in-depth into the results of this winter outlook, underlining the two-step approach used to realise the document:

  • Isolated mode: the study demonstrates that not all the countries analysed can self-sustain, while others show no adequacy issues at all.
  • Interconnected mode: it was possible to highlight how adequacy challenges can be mitigated through the development of interconnection projects and collaboration with neighbouring countries.

This Winter Outlook is the second of six seasonal adequacy studies and one mid-term adequacy study planned during the implementation of the TEASIMED 2 project: the next step will be the release of the Summer Outlook, which is expected in May 2024.